Added to YB: 2024-06-28
Pitch date: 2024-06-27
BOLT [bullish]
Bolt Biotherapeutics, Inc.
-63.73%
current return
Author Info
Special Situation Investments focuses on event-driven trades and low risk arbitrage opportunities with short term catalysts. Sign up for the newsletter.
Company Info
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer.
Market Cap
$19.2M
Pitch Price
$15.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.25
P/E
-0.29
EV/Sales
-1.68
Sector
Biotechnology
Category
special_situation
BOLT: Potential Liquidation or Buyout with Significant Insider and Activist Stakes
BOLT: Biopharma at 50% discount to liquidation value. Halted key asset, cut workforce 50%. CEO replaced by CFO. Activist Kevin Tang owns 10%. Ex-CEO holds 5.7%. 30% insider ownership. 50%+ discount to liquidation value (incl. 2Q cash burn). Mgmt reshuffle suggests continuation, but potential for liquidation/buyout. Biotech PE funds on board support development.
Read full article (2 min)